- Home
- ANTX vs DYAI Comparison
ANTX vs DYAI Comparison
Compare ANTX & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- DYAI
- Stock Information
- Founded
- ANTX 2017
- DYAI 1979
- Country
- ANTX United States
- DYAI United States
- Employees
- ANTX N/A
- DYAI N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANTX Health Care
- DYAI Health Care
- Exchange
- ANTX Nasdaq
- DYAI Nasdaq
- Market Cap
- ANTX 33.2M
- DYAI 28.3M
- IPO Year
- ANTX 2022
- DYAI 2004
- Fundamental
- Price
- ANTX $1.07
- DYAI $0.98
- Analyst Decision
- ANTX Buy
- DYAI Strong Buy
- Analyst Count
- ANTX 2
- DYAI 1
- Target Price
- ANTX $2.00
- DYAI $6.00
- AVG Volume (30 Days)
- ANTX 287.6K
- DYAI 63.9K
- Earning Date
- ANTX 08-12-2025
- DYAI 08-12-2025
- Dividend Yield
- ANTX N/A
- DYAI N/A
- EPS Growth
- ANTX N/A
- DYAI N/A
- EPS
- ANTX N/A
- DYAI N/A
- Revenue
- ANTX N/A
- DYAI $3,554,344.00
- Revenue This Year
- ANTX N/A
- DYAI $22.56
- Revenue Next Year
- ANTX N/A
- DYAI $30.95
- P/E Ratio
- ANTX N/A
- DYAI N/A
- Revenue Growth
- ANTX N/A
- DYAI 57.59
- 52 Week Low
- ANTX $0.87
- DYAI $0.91
- 52 Week High
- ANTX $3.07
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- ANTX 42.84
- DYAI 53.08
- Support Level
- ANTX $1.07
- DYAI $0.91
- Resistance Level
- ANTX $1.11
- DYAI $0.99
- Average True Range (ATR)
- ANTX 0.04
- DYAI 0.06
- MACD
- ANTX 0.00
- DYAI 0.01
- Stochastic Oscillator
- ANTX 7.14
- DYAI 59.93
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.